Fundraising Fox

Rocket Pharma

4 known investors

rocketpharma.com ↗

Rocket Pharmaceuticals develops gene therapies to treat patients with rare genetic diseases, focusing on cardiovascular and hematologic disorders. The company creates potentially curative treatments at the genetic level for inherited and rare diseases.

BiotechDigital HealthMedical Devicesin /rocket-pharmaceuticals-ltd@RocketPharma

Founders & leadership

GS
Gaurav ShahCo-founder & Chief Executive Officer
RW
Roderick WongDirector
NY
Naveen YalamanchiDirector

Investors · 4

Avoro Capital AdvisorsNew York
Broadview VenturesBoston
Civilization Ventures Management, LlcTiburon · $1M – $10M
RTW Investments L.P.reportedNew Yorkvia Naveen Yalamanchi · board

Reported raises · per SEC filings

Form D private placements
▶$25.1MraisedMay 2017 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Naveen YalamanchiDirector
  • Gaurav ShahExecutive Officer
  • Roderick WongDirector
Offering amount
$30.1M
Amount sold
$25.1M
Minimum investment
$24K
First sale
Feb 2017
Incorporated
Other, Cayman Islands, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.4MraisedJan 2016 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Roderick WongDirector
  • Gaurav ShahExecutive Officer
  • Naveen YalamanchiDirector
Offering amount
$38M
Amount sold
$16.4M
Minimum investment
$75K
First sale
Dec 2015
Incorporated
Other, Cayman Islands, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news